Update on HIV lymphoma.
In industrialized nations people infected with HIV remain at increased risk for malignancies despite highly active antiretroviral therapy. In these countries, lymphoma is the most common HIV-associated malignancy. This review summarizes progress from January 2005 to February 2007. The majority of investigation has been in diffuse large B cell lymphoma, with infusional therapy remaining promising but cumbersome. Rituximab likely improves complete response rates, and, possibly overall survival, but is likely associated with increased infections in a subset of patients with very low CD4 counts. Biologic insights have been attained in the spectrum of HIV-associated non-Hodgkin's lymphoma, Hodgkin's lymphoma, and virologic coinfections. Overall, the outcome for non-Hodgkin's lymphoma and Hodgkin's lymphoma in the setting of HIV continues to improve as insights into the pathophysiology and treatment advance.
Noy
Ariela
A
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10064, USA. noya@mskcc.org
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy / Q000821:virology; D011379:Prognosis
D044966:Anti-Retroviral Agents
N Engl J Med. 1993 Sep 30;329(14 ):987-94
8141877
Exp Hematol. 2005 Apr;33(4):487-94
15781340
Blood. 2005 Nov 1;106(9):3166-74
16014568
Blood. 2004 Jan 1;103(1):275-82
14504078
Blood. 2006 Jan 1;107(1):13-20
16099881
Br J Cancer. 2006 Dec 4;95(11):1598-602
17106439
Clin Lymphoma Myeloma. 2006 Mar;6(5):399-402
16640817
Clin Infect Dis. 2006 Feb 15;42(4):e21-5
16421782
Ann Hematol. 2005 Oct;84(10):661-6
15875183
J Clin Oncol. 2005 Jul 1;23(19):4430-8
15883411
Blood. 1997 Feb 15;89(4):1413-20
9028965
Blood. 2005 Jan 15;105(2):496-502
15358629
Am J Surg Pathol. 2005 Dec;29(12):1633-41
16327436
Ann Intern Med. 2005 Aug 16;143(4):265-73
16103470
Clin Infect Dis. 2005 Apr 1;40(7):1022-7
15824995
AIDS Res Hum Retroviruses. 2005 Mar;21(3):214-20
15795527
AIDS. 2005 Oct 14;19(15):1711-2
16184051
Blood. 2003 Jun 15;101(12):4653-9
12609827
J Clin Oncol. 2006 Sep 1;24(25):4123-8
16896005
Cancer. 2002 Mar 1;94(5):1492-9
11920506
Cancer. 2003 Sep 15;98(6):1196-205
12973843
Blood. 2006 Apr 1;107(7):3014-5
16554492
AJNR Am J Neuroradiol. 2005 Sep;26(8):1973-9
16155145
J Clin Oncol. 2000 Oct 1;18(19):3325-30
11013271
Transplantation. 2005 Sep 15;80(5):673-82
16177644
Blood. 2001 Dec 15;98(13):3857-9
11739198
Blood. 2006 Apr 15;107(8):3412-4
16597601
J Clin Oncol. 2005 Nov 1;23(31):8116-7
16258111
Br J Dermatol. 2005 Oct;153(4):828-32
16181470
Blood. 2005 Mar 1;105(5):1891-7
15550484
Ann Oncol. 2004 Nov;15(11):1673-9
15520070
Int J Cancer. 2005 Aug 10;116(1):161-3
15756687
J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):293-9
15980688
Blood. 2006 May 15;107(10):3832-40
16410446
Eur J Haematol. 2005 Jan;74(1):70-2
15613110
Nature. 2000 Feb 3;403(6769):503-11
10676951
J Clin Oncol. 2005 Jul 1;23(19):4372-80
15994147
Blood. 2007 Apr 15;109(8):3214-8
17209054
Leuk Lymphoma. 2005 Feb;46(2):207-15
15621803
Blood. 2005 Sep 1;106(5):1538-43
15914552
J Clin Oncol. 2005 Nov 1;23(31):8132-3; author reply 8133-4
16258119
Leukemia. 2005 May;19(5):851-5
15744337
HIV Med. 2005 Jan;6(1):21-6
15670248
Blood. 2005 Sep 1;106(5):1762-9
15905193
Haematologica. 2005 Jul;90(7):990-2
15996943
Blood. 2006 Dec 1;108(12):3786-91
16917006
Clin Infect Dis. 2006 Feb 1;42(3):411-7
16392091
Cell Res. 2005 Nov-Dec;15(11-12):947-52
16354573
J Cell Biol. 2003 Jun 9;161(5):839-43
12796473
Virology. 2005 Nov 10;342(1):38-46
16122775
J Clin Oncol. 2003 Dec 1;21(23):4423-7
14581441
J Clin Oncol. 2005 Nov 20;23(33):8477-82
16230675